News Samsung's new smart watch has blood pressure function Samsung has followed the example of Apple and launched a smart watch with a focus on improving the wearer’s health.
News Verily unveils the Study Watch, a clinical trials-only weara... Device will be used in several upcoming clinical studies.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
